Prinova US LLC has entered into an agreement with SLS Nutraceuticals Pte. Ltd., a subsidiary of biotechnology company Senescence Life Sciences Pte. Ltd., in a partnership that will bring a line of clinically studied cognitive ingredients to the U.S. market.
 
Under the agreement, Prinova will have exclusive distribution rights for SLS Nutraceuticals patent pending line of ingredient complexes: NeuroBloom, NeuroScope, and NeuroZone. 
 
The flagship ingredient NeuroBloom is said to address multiple facets of cognitive performance and brain health, with the ultimate goal of delaying cognitive decline associated with stress, lack of sleep, and aging. NeuroScope and NeuroZone are further tailored to address the unique cognitive requirements of e-Gamers and MMA athletes.
 
As a manufacturer of functional premixes, Prinova will produce all proprietary blends in house.
 
Prinova’s business development manager of innovation, Dan Force, described the new partnership, “The technology developed by SLS [Nutraceuticals] delivers on our customers’ demands for next generation cognitive ingredients. The growth we’ve seen in the space over the last 18 months has been largely based on high stim products that don’t focus on the underlying mechanisms of cognitive decline. NeuroBloom tackles the problem at its core and provides a long-term, healthy solution to keep our brains healthy and fit. For our customers, this presents an opportunity to expand their cognitive portfolio and offer a more holistic solution to consumers.”
 
SLS Nutraceuticals top neuroscientist and founder Shawn Watson describe the partnership, saying, “Our new partnership with Prinova gives us access to not only one of the world’s leading manufacturers, but also a team of innovative professionals with a deep understanding of consumer trends, and the ability to provide a suite of tailored products to their clients. As our solution spans everyone from 25-year-old gamers, who eat poorly and sleep less, to senior citizens worried about age-related memory decline, we needed a partner who knew how to effectively communicate the benefits of our products to broad consumer base. Prinova has proven to be this [partner].”
 
Watson added that Prinova’s position as a leading premix blender was also an important synergy. “Quality and safety are always a top priority, so we we’re happy to see the formula be produced under the same roof as distribution.” 
 
Watson also elaborated on how the new line of nootropics works. “The modern lifestyle is hard on our bodies and our brains. Factors such as stress, poor diet, lack of sleep, and aging cause a slow build-up of damage in our brain which impacts our cognitive capabilities, and how we perform at work and home. One of the first neurological components to be damaged are the lipids (fats), that make up about 60% of our brain. Our technology is centered around repairing and recycling these lipids to promote long term brain health and provide a non-stimulant solution to increase cognitive performance.”
 
He continued to say “While the ingredients themselves come with strong functional benefits for the brain, as our first pilot clinical trial indicated, the strength is in the mix. Using our patent-pending method, the ingredients work synergistically to increase neuropsychological measures of cognitive performance.”